Survival effect of implementing national treatment strategies for curatively resected colonic and rectal cancer

British Journal of Surgery

Volumn 98, Issue 5, 2011, Pages 716-723

  Nedrebo B S ^a,b   Soreide K ^a,b   Eriksen, M T ^d   Dorum L M ^e   Kvaloy J T ^c   Soreide J A ^a,b   Korner H ^a,b  

^a STAVANGER UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c UNIVERSITY OF STAVANGER   (Norway)

^d ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^e CANCER REGISTRY OF NORWAY   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79953680733     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.7426     Document Type: Article

References (27)

1. Weitz J, Koch M, Debus J, Höhler T, Galle PR, Büchler MW,. Colorectal cancer. Lancet 2005; 365: 153-165. (Pubitemid 40091806)
2. Møller B, Fekjaer H, Hakulinen T, Tryggvadottir L, Storm HH, Talbäck M, et al., Prediction of cancer incidence in the Nordic countries up to the year 2020. Eur J Cancer Prev 2002; 11 (Suppl 1): S1-S96. (Pubitemid 34759915)
3. Angell-Andersen E, Tretli S, Coleman MP, Langmark F, Grotmol T,. Colorectal cancer survival trends in Norway 1958-1997. Eur J Cancer 2004; 40: 734-742. (Pubitemid 38326624)
4. Bray F, Wibe A, Dørum LM, Møller B,. [Epidemiology of colorectal cancer in Norway.] Tidsskr Nor Laegeforen 2007; 127: 2682-2687.
5. Birgisson H, Talbäck M, Gunnarsson U, PÅhlman L, Glimelius B,. Improved survival in cancer of the colon and rectum in Sweden. Eur J Surg Oncol 2005; 31: 845-853. (Pubitemid 41435253)
6. PÅhlman L, Gunnarsson U, Karlbom U,. The influence on treatment outcome of structuring rectal cancer care. Eur J Surg Oncol 2005; 31: 645-649. (Pubitemid 40975246)
7. MacFarlane JK, Ryall RD, Heald RJ,. Mesorectal excision for rectal cancer. Lancet 1993; 341: 457-460. (Pubitemid 23054519)
8. Hermanek P, Wiebelt H, Staimmer D, Riedl S,. Prognostic factors of rectum carcinoma - experience of the German Multicentre Study SGCRC. German Study Group Colo-Rectal Carcinoma. Tumori 1995; 81: 60-64.
9. Wibe A, Eriksen MT, Syse A, Myrvold HE, Søreide O,; Norwegian Rectal Cancer Group. Total mesorectal excision for rectal cancer - what can be achieved by a national audit? Colorectal Dis 2003; 5: 471-477. (Pubitemid 37080656)
10. Wibe A, Møller B, Norstein J, Carlsen E, Wiig JN, Heald RJ, et al., A national strategic change in treatment policy for rectal cancer - implementation of total mesorectal excision as routine treatment in Norway. A national audit. Dis Colon Rectum 2002; 45: 857-866. (Pubitemid 34761463)
11. Eriksen MT, Wibe A, Hestvik UE, Haffner J, Wiig JN,; Norwegian Rectal Cancer Group; Norwegian Gastrointestinal Cancer Group. Surgical treatment of primary locally advanced rectal cancer in Norway. Eur J Surg Oncol 2006; 32: 174-180. (Pubitemid 43257119)
12. Tveit KM, Dahl O, Gerner T,. [Chemotherapy in colorectal cancer. Recommendations of the Norwegian Gastrointestinal Cancer Group.] Tidsskr Nor Laegeforen 1996; 116: 357-360.
13. Wibe A, Carlsen E, Dahl O, Tveit KM, Weedon-Fekjaer H, Hestvik UE, et al., Nationwide quality assurance of rectal cancer treatment. Colorectal Dis 2006; 8: 224-229. (Pubitemid 43379509)
14. Hansen MH, Kjaeve J, Revhaug A, Eriksen MT, Wibe A, Vonen B, et al., Impact of radiotherapy on local recurrence of rectal cancer in Norway. Br J Surg 2007; 94: 113-118. (Pubitemid 46142741)
15. Dickman PW, Adami HO,. Interpreting trends in cancer patient survival. J Intern Med 2006; 260: 103-117. (Pubitemid 44051335)
16. Pohar M, Stare J,. Relative survival analysis in R. Comput Methods Programs Biomed 2006; 81: 272-278. (Pubitemid 44316489)
17. Pohar M, Stare J,. Making relative survival analysis relatively easy. Comput Biol Med 2007; 37: 1741-1749. (Pubitemid 47575511)
18. Søreide K, Glomsaker T, Søreide JA,. Surgery in Norway: beyond the scalpel in the 21st century. Arch Surg 2008; 143: 1011-1016.
19. Wibe A, Eriksen MT, Syse A, Tretli S, Myrvold HE, Søreide O, et al., Effect of hospital caseload on long-term outcome after standardization of rectal cancer surgery at a national level. Br J Surg 2005; 92: 217-224. (Pubitemid 40269338)
20. Mitry E, Bouvier AM, Esteve J, Faivre J,. Improvement in colorectal cancer survival: a population-based study. Eur J Cancer 2005; 41: 2297-2303. (Pubitemid 41415606)
21. Engeland A, Haldorsen T, Dickman PW, Hakulinen T, Møller TR, Storm HH, et al., Relative survival of cancer patients - a comparison between Denmark and the other Nordic countries. Acta Oncol 1998; 37: 49-59. (Pubitemid 28179800)
22. Wong RK, Tandan V, De Silva S, Figueredo A,. Pre-operative radiotherapy and curative surgery for the management of localized rectal carcinoma. Cochrane Database Syst Rev 2007; (2)CD002102.
23. Peeters KC, Marijnen CA, Nagtegaal ID, Kranenbarg EK, Putter H, Wiggers T, et al., The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg 2007; 246: 693-701. (Pubitemid 350035641)
24. van Gijn W, Krijnen P, Lemmens VE, den Dulk M, Putter H, van de Velde CJ,. Quality assurance in rectal cancer treatment in the Netherlands: a catch up compared to colon cancer treatment. Eur J Surg Oncol 2009; 36: 340-344.
25. Stelzner S, Hellmich G, Koch R, Witzigmann H,. Exactitude of relative survival compared with cause-specific survival and competing risk estimations based on a clinical database of patients with colorectal carcinoma. Dis Colon Rectum 2009; 52: 1264-1271.
26. Feinstein AR, Sosin DM, Wells CK,. The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med 1985; 312: 1604-1608. (Pubitemid 15062653)
27. Engholm G, Kejs AM, Brewster DH, Gaard M, Holmberg L, Hartley R, et al., Colorectal cancer survival in the Nordic countries and the United Kingdom: excess mortality risk analysis of 5 year relative period survival in the period 1999-2000. Int J Cancer 2007; 121: 1115-1122. (Pubitemid 47101651)